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globally should start to enable clinicians to better formulate 
accurate future diagnoses and at times prognoses.
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MicroRNAs are understood to play a functional role within the 
establishment of epigenetic marks and are in turn under epigenetic 
control. Emerging evidence suggests microRNAs are vital for 
both kidney development and renal function. This study aimed to 
identify differential methylation affecting microRNAs in patients 
with end-stage renal disease (ESRD).
Methylation status was determined for 485,577 unique CpG 
sites in 105 individuals with ESRD and 52 donor controls with 
no evidence of renal disease using the HumanMethylation450K 
BeadChip array (Illumina). Statistically significant associations 
(P<10-8) were observed between case and control groups for 
both unique CpG sites within microRNAs and their target genes, 
identified using miRDB (an online database for microRNA target 
prediction and functional annotations).
CpG sites (n=11) within top-ranked microRNAs (n=42) alongside 
848 CpGs in 198 target genes were evaluated in genotyped renal 
transplant samples to detect methylation quantitative trait loci 
(meQTLs) associated with ESRD. Following allelic association 
PLINK analysis, 116 SNPs were determined from the investigated 
CpG sites, 12 of which were located in genes previously linked 
with renal disease or microRNAs.
Blood-derived Ion Total RNA-Seq v2 analysis was performed 
on10ESRD samples and 29 controls (with no evidence of renal 
disease)to determine the expression levels of the microRNAs and 
target genes. Sequencing was completed using the Ion Proton™ 
(Thermo Fisher Scientific) and the most significant results 
wereMIR548H4 (5.79x10-6) and WASF3 (5.59x10-9) respectively, 
showing increased expression within the ESRD samples.
This study has identified microRNA-related differential 
methylation with supporting gene expression data, associated with 
ESRD.
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Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative 
disease characterized by rapid-onset loss of upper and lower 
motor neurones, resulting in progressive paralysis and death from 
respiratory failure. Schizophrenia is a neuropsychiatric disease 
with positive symptoms, negative symptoms and impairment 
over a range of cognitive abilities. We have recently shown that 
schizophrenia occurs more frequently than expected in the pedigrees 
of ALS patients, suggesting an aetiological relationship between 
both diseases. Using linkage disequilibrium score regression 
with summary statistics for GWAS of ALS and schizophrenia 
comprising over 100,000 unique individuals, we estimated the 
genetic correlation between ALS and schizophrenia to be 14.3% 
(95% CI 7.05-21.6; p = 1×10-4). Up to 0.12% of the variance in 
ALS was explained by schizophrenia polygenic risk scores (p 
= 8.4×10). We leveraged the apparent pleiotropic relationship 
between ALS and schizophrenia to identify five potential novel 
ALS-associated genomic loci at conditional false discovery rate 
< 0.01. Diagnostic misclassification in the schizophrenia cohort 
did not contribute significantly to our observations (BUHMBOX 
p = 0.94) and we estimated that 4.86% (2.47-7.13%) of ALS cases 
would need to be misdiagnosed as schizophrenia to observe our 
genetic correlation estimate under a true genetic correlation of 
0%. Our results indicate that the lifetime risk for comorbid ALS 
and schizophrenia increases from 1 in 40,000 to 1 in 34,336, 
which would require an incident cohort of 16,488 ALS patients to 
observe epidemiologically. Our findings suggest shared underlying 
biology between ALS and schizophrenia which will direct novel 
approaches in research and therapeutic development.
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Background: Imprinted genes are autosomal, but only expressed 
from one parental allele and are often clustered in small groups. 
They play an important role in the regulation of normal mammalian 
